Companies: 10,795·Total market cap: $144.5T
Allurion Technologies Inc.

Allurion Technologies Inc.

ALUROTCHealthcare● Active
$0.74
$-0.13(-15.02%)
Market Cap$5582070
P/E Ratio
52W High$3.33
52W Low$0.23

Allurion Technologies Inc. (ALUR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

alur · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Allurion Technologies Inc. (ALUR) measures how much investors pay for each dollar of the company's trailing earnings. ALUR's current PE ratio of N/A is calculated by dividing its stock price of $0.74 by its TTM earnings per share of -$0.25.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-1.35
Based on 1 analyst
EPS (TTM)
-$0.25
TTM · diluted EPS
PEG Ratio
-0.02
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Allurion Technologies Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Allurion Technologies Inc.
Allurion Technologies Inc.You
ALUR
$6MN/A-$0.25
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
ADAP
$75MN/A-$0.28
Aethlon Medical, Inc.
Aethlon Medical, Inc.
AEMD
$2MN/A-$85.77
Envoy Medical, Inc.
Envoy Medical, Inc.
COCH
$14MN/A-$1.21
Co-Diagnostics, Inc.
Co-Diagnostics, Inc.
CODX
$6MN/A-$35.25
Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc.
ERNA
$2MN/A-$55.83
Lifeward Ltd.
Lifeward Ltd.
LFWD
$11MN/A-$1.72

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.38
2024-12-31
FY2024
$-11.64
2023-12-31
FY2023
$-57.83
2022-12-31
FY2022
$-37.75
2021-12-31
FY2021
$-0.23
2020-12-31
FY2020
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Allurion Technologies Inc. (ALUR) measures how much investors pay for each dollar of the company's trailing earnings. ALUR's current PE ratio of N/A is calculated by dividing its stock price of $0.74 by its TTM earnings per share of -$0.25.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.74 ÷ -$0.25 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ALUR pe ratio · 6 questions

ALUR's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.74 and TTM EPS of -$0.25. Data sourced from Financial Modeling Prep via ALUR's SEC 10-K and 10-Q filings.

ALUR PE ratioWhat is ALUR PE ratioCurrent PE ratio of ALURALUR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Allurion Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08